Keywords: Pakistant pharmaceutival market, BMI, Forecasts, Hepatitis C,, Getz Pharma, Health infrasructure
Pakistan pharmaceutical market to grow to $1.74 billion this year
Article | 08 October 2010
Combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan will increase from 136.61 billion Pak rupees ($1.67 billion) in 2009 to 153.22 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
